scispace - formally typeset
D

David W. Boykin

Researcher at Georgia State University

Publications -  406
Citations -  10965

David W. Boykin is an academic researcher from Georgia State University. The author has contributed to research in topics: DNA & Aryl. The author has an hindex of 54, co-authored 397 publications receiving 10212 citations. Previous affiliations of David W. Boykin include King Faisal University.

Papers
More filters
Journal ArticleDOI

Human African trypanosomiasis: pharmacological re-engagement with a neglected disease

TL;DR: The challenges of chemotherapy for human African trypanosomiasis (HAT) are discussed, and the few drugs registered for use against the disease are unsatisfactory for a number of reasons.
Journal ArticleDOI

Structure-In Vitro Activity Relationships of Pentamidine Analogues and Dication-Substituted Bis-Benzimidazoles as New Antifungal Agents

TL;DR: It is clear from the data presented here that further studies on the structure-activity relationships, mechanisms of action and toxicities, and in vivo efficacies of these compounds are warranted to determine their clinical potential.
Journal ArticleDOI

Synthesis of some new 2-substituted-phenyl-1H-benzimidazole-5-carbonitriles and their potent activity against Candida species.

TL;DR: New 2-substituted-phenyl-1H-benzimidazole-5-carboxylic acids, and cyano substituted compounds 53, 57, 58 and 61 exhibited the greatest activity with MIC values similar to that of fluconazole.
Journal ArticleDOI

Antiparasitic compounds that target DNA.

TL;DR: Synthetic heterocyclic diamidines have excellent activity against eukaryotic parasites that cause diseases such as sleeping sickness and leishmania and adversely affect millions of people each year.
Journal ArticleDOI

Structure-specific recognition of quadruplex DNA by organic cations: influence of shape, substituents and charge.

TL;DR: In this paper, the authors used surface plasmon resonance and isothermal titration calorimetry to show that binding affinity and selectivity of a series of quadruplex end-stacking molecules to human telomeric DNA are sensitive to compound shape as well as substituent type and position.